BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18439106)

  • 1. BRCA2 gene mutations in Slovenian male breast cancer patients.
    Besic N; Cernivc B; de Grève J; Lokar K; Krajc M; Novakovic S; Zgajnar J; Teugels E
    Genet Test; 2008 Jun; 12(2):203-9. PubMed ID: 18439106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1/BRCA2 mutation status and clinical-pathologic features of 108 male breast cancer cases from Tuscany: a population-based study in central Italy.
    Ottini L; Rizzolo P; Zanna I; Falchetti M; Masala G; Ceccarelli K; Vezzosi V; Gulino A; Giannini G; Bianchi S; Sera F; Palli D
    Breast Cancer Res Treat; 2009 Aug; 116(3):577-86. PubMed ID: 18819001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five recurrent BRCA1/2 mutations are responsible for cancer predisposition in the majority of Slovenian breast cancer families.
    Krajc M; Teugels E; Zgajnar J; Goelen G; Besic N; Novakovic S; Hocevar M; De Grève J
    BMC Med Genet; 2008 Sep; 9():83. PubMed ID: 18783588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of BRCA1 and BRCA2 mutations in male breast cancer patients in Canada.
    Wolpert N; Warner E; Seminsky MF; Futreal A; Narod SA
    Clin Breast Cancer; 2000 Apr; 1(1):57-63; discussion 64-5. PubMed ID: 11899391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic testing results in Slovenian male breast cancer cohort indicate the BRCA2 7806-2A > G founder variant could be associated with higher male breast cancer risk.
    Strojnik K; Krajc M; Dragos VS; Stegel V; Novakovic S; Blatnik A
    Breast Cancer Res Treat; 2021 Aug; 188(3):811-820. PubMed ID: 33891299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BRCA1/BRCA2 rearrangements and CHEK2 common mutations are infrequent in Italian male breast cancer cases.
    Falchetti M; Lupi R; Rizzolo P; Ceccarelli K; Zanna I; Calò V; Tommasi S; Masala G; Paradiso A; Gulino A; Giannini G; Russo A; Palli D; Ottini L
    Breast Cancer Res Treat; 2008 Jul; 110(1):161-7. PubMed ID: 17661168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline deleterious mutations in genes other than BRCA2 are infrequent in male breast cancer.
    Fostira F; Saloustros E; Apostolou P; Vagena A; Kalfakakou D; Mauri D; Tryfonopoulos D; Georgoulias V; Yannoukakos D; Fountzilas G; Konstantopoulou I
    Breast Cancer Res Treat; 2018 May; 169(1):105-113. PubMed ID: 29335925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA2 founder mutation in Slovenian breast cancer families.
    Krajc M; De Grève J; Goelen G; Teugels E
    Eur J Hum Genet; 2002 Dec; 10(12):879-82. PubMed ID: 12461697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
    Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
    Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA2 mutations in 154 finnish male breast cancer patients.
    Syrjäkoski K; Kuukasjärvi T; Waltering K; Haraldsson K; Auvinen A; Borg A; Kainu T; Kallioniemi OP; Koivisto PA
    Neoplasia; 2004; 6(5):541-5. PubMed ID: 15548363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L; Masala G; D'Amico C; Mancini B; Saieva C; Aceto G; Gestri D; Vezzosi V; Falchetti M; De Marco M; Paglierani M; Cama A; Bianchi S; Mariani-Costantini R; Palli D
    Cancer Res; 2003 Jan; 63(2):342-7. PubMed ID: 12543786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Family history of breast cancer in men with non-BRCA male breast cancer: implications for cancer risk counseling.
    Calip GS; Kidd J; Bernhisel R; Cox HC; Saam J; Rauscher GH; Lancaster JM; Hoskins KF
    Breast Cancer Res Treat; 2021 Jan; 185(1):195-204. PubMed ID: 32918117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of candidate genes in Israeli male breast cancer cases.
    Schayek H; Korach H; Laitman Y; Bernstein-Molho R; Friedman E
    Breast Cancer Res Treat; 2018 Jul; 170(2):399-404. PubMed ID: 29560538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic features and genetic characterization of male breast cancer families: identification of two recurrent BRCA2 mutations in north-east of Italy.
    Miolo G; Puppa LD; Santarosa M; De Giacomi C; Veronesi A; Bidoli E; Tibiletti MG; Viel A; Dolcetti R
    BMC Cancer; 2006 Jun; 6():156. PubMed ID: 16764716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects.
    Díez O; Osorio A; Durán M; Martinez-Ferrandis JI; de la Hoya M; Salazar R; Vega A; Campos B; Rodríguez-López R; Velasco E; Chaves J; Díaz-Rubio E; Jesús Cruz J; Torres M; Esteban E; Cervantes A; Alonso C; San Román JM; González-Sarmiento R; Miner C; Carracedo A; Eugenia Armengod M; Caldés T; Benítez J; Baiget M
    Hum Mutat; 2003 Oct; 22(4):301-12. PubMed ID: 12955716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.
    Fourati A; Louchez MM; Fournier J; Gamoudi A; Rahal K; El May MV; El May A; Revillion F; Peyrat JP
    Bull Cancer; 2014 Nov; 101(11):E36-40. PubMed ID: 25418591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline mutations in the BRCA1 and BRCA2 genes in Turkish breast/ovarian cancer patients.
    Manguoglu AE; Lüleci G; Ozçelik T; Colak T; Schayek H; Akaydin M; Friedman E
    Hum Mutat; 2003 Apr; 21(4):444-5. PubMed ID: 12655560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results.
    Pritzlaff M; Summerour P; McFarland R; Li S; Reineke P; Dolinsky JS; Goldgar DE; Shimelis H; Couch FJ; Chao EC; LaDuca H
    Breast Cancer Res Treat; 2017 Feb; 161(3):575-586. PubMed ID: 28008555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRCA1 and BRCA2 mutations in a population-based study of male breast cancer.
    Basham VM; Lipscombe JM; Ward JM; Gayther SA; Ponder BA; Easton DF; Pharoah PD
    Breast Cancer Res; 2002; 4(1):R2. PubMed ID: 11879560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The occurrence of germline BRCA1 and BRCA2 sequence alterations in Slovenian population.
    Stegel V; Krajc M; Zgajnar J; Teugels E; De Grève J; Hočevar M; Novaković S
    BMC Med Genet; 2011 Jan; 12():9. PubMed ID: 21232165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.